SCHEMBL6745271

SCHEMBL6745271

COC(=O)C=C1CC[C@@H](C(=O)OC(C)(C)C)N1Cc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MTNR1A P48039 5/20 0.39
MTNR1B P49286 1/20 0.39
GPR119 Q8TDV5 1/20 0.39
TRPM8 Q7Z2W7 1/20 0.38
CYP3A4 P08684 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
P2RX7 Q99572 2/20 0.37
POLB P06746 2/20 0.37
POLA1 P09884 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6745269 1.00 KMT2A (0.44) KMT2AL3MBTL1MTNR1AMTNR1BGPR119
SCHEMBL25405985 0.86 MTNR1A (0.41) KMT2AMTNR1AMTNR1BP2RX7
SCHEMBL25405978 0.86 MTNR1A (0.41) KMT2AMTNR1AMTNR1BP2RX7
SCHEMBL7020132 0.81 KMT2A (0.51) KMT2AL3MBTL1CYP3A4ALDH1A1P2RX7
SCHEMBL28065531 0.81 KMT2A (0.51) KMT2AL3MBTL1CYP3A4ALDH1A1P2RX7
SCHEMBL28065530 0.79 KMT2A (0.44) KMT2AL3MBTL1MTNR1AMTNR1BGPR119
SCHEMBL7021591 0.79 KMT2A (0.44) KMT2AL3MBTL1MTNR1AMTNR1BGPR119
SCHEMBL9352229 0.75 KMT2A (0.55) KMT2AL3MBTL1TRPM8CYP3A4KDM4E
SCHEMBL9356309 0.74 KMT2A (0.56) KMT2AL3MBTL1GPR119TRPM8CYP3A4
SCHEMBL9352224 0.74 KMT2A (0.56) KMT2AL3MBTL1GPR119TRPM8CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6685617-B1 4-(((-1-CARBOXY-2-(4-((2,6-DICHLOROBENZOYL)AMINE)PHENYL)ETHYL) AMINO)CARBONYL)-3-OXO-3-THIAZOLIDINEBUTANOIC ACID, USED AS ANTAGONISTS FOR CELLULAR ADHESION MOLECULES, AND ADMINISTERED AS ANTIINFLAMMATORY AGENTS PHARMACIA & UPJOHN COMPANY 2004-02-03 US disclosed